Utilization and efficacy of second-line targeted therapy in metastatic renal cell carcinoma: data from a national registry
Pre-publication versions of this article are available by contacting firstname.lastname@example.org.
|21 Nov 2016||Submitted||Original manuscript|
|4 Apr 2017||Reviewed||Reviewer Report - Pablo Maroto|
|5 Jul 2017||Reviewed||Reviewer Report - Frede Donskov|
|8 Oct 2017||Author responded||Author comments - Radek Lakomy|
|Resubmission - Version 2|
|8 Oct 2017||Submitted||Manuscript version 2|
|13 Nov 2017||Reviewed||Reviewer Report - Frede Donskov|
|2 Dec 2017||Author responded||Author comments - Radek Lakomy|
|Resubmission - Version 3|
|2 Dec 2017||Submitted||Manuscript version 3|
|8 Dec 2017||Editorially accepted|
|21 Dec 2017||Article published||10.1186/s12885-017-3901-5|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting email@example.com.
You can find further information about the peer review system here.